Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2026-03-04 @ 10:43 PM
Study NCT ID:
NCT01431794
Status:
TERMINATED
Last Update Posted:
2020-01-22
First Post:
2011-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-19
First Submit QC Date:
None
Study First Post Date:
2011-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-01
Results First Submit QC Date:
None
Results First Post Date:
2019-06-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-17
Last Update Post Date:
2020-01-22
Last Update Post Date Type:
ACTUAL